机器人治疗联合无创脑刺激对卒中后上肢康复的效果:随机临床试验的系统综述与Meta分析
该系统综述与Meta分析纳入8项随机临床试验,评估无创脑刺激作为机器人辅助治疗附加干预对卒中患者上肢运动损伤或活动结局的效果。结果显示,身体结构/功能域(MD=0.15,95%CI=-3.10至3.40,P=0.93,I²=0%)和活动限制域(SMD=0.03,95%CI=-0.28至0.33,P=0.87,I²=0%)的合并效应均不显著且同质。目前证据不足以支持无创脑刺激作为机器人辅助治疗的附加干预。
要点
- 无创脑刺激联合机器人治疗对上肢运动功能合并效应不显著(MD=0.15,P=0.93)。
- 对上肢活动限制合并效应亦不显著(SMD=0.03,P=0.87),异质性均为0%。
- 现有随机临床试验证据不足以推荐该联合方案用于卒中上肢康复。
核心结论
- 目前证据不足以支持无创脑刺激作为机器人辅助治疗的附加干预改善卒中患者上肢运动功能或活动。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA方案并在PROSPERO注册(CRD42017054563)。
- 检索7个数据库及灰色文献,共获取1176条记录,最终纳入8项随机临床试验。
- 纳入标准为包含上肢身体结构/功能或活动限制结局指标的随机临床试验。
- 采用Grade-Pro软件评估证据质量。
主要发现
- 身体结构/功能域合并效应量不显著(MD=0.15,95%CI=-3.10至3.40,P=0.93,I²=0%)。
- 活动限制域合并效应量不显著(SMD=0.03,95%CI=-0.28至0.33,P=0.87,I²=0%)。
关键数值与推荐
- 亚组分析按卒中后阶段、设备特征(臂部支撑、涉及关节、单侧或双侧训练)、无创脑刺激范式、刺激时机及治疗次数进行。
- 合并效应采用均值差(MD)或标准化均值差(SMD)及95%置信区间表示。
临床怎么用
- 临床不应仅基于现有证据将无创脑刺激作为机器人辅助治疗的常规附加干预用于卒中上肢康复。
- 需结合患者个体情况与最新证据谨慎决策,并关注后续高质量随机临床试验结果。
局限性
- 纳入的随机临床试验数量有限(8项),证据不足以得出明确结论。
- 原文未报告纳入试验的具体样本量、刺激参数及治疗剂量等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robot-assisted therapy and noninvasive brain stimulation (NIBS) are promising strategies for stroke rehabilitation. OBJECTIVE: This systematic review and meta-analysis aims to evaluate the evidence of NIBS as an add-on intervention to robotic therapy in order to improve outcomes of upper-limb motor impairment or activity in individuals with stroke. METHODS: This study was performed according to the PRISMA Protocol and was previously registered on the PROSPERO Platform (CRD42017054563). Seven databases and gray literature were systematically searched by 2 reviewers, and 1176 registers were accessed. Eight randomized clinical trials with upper-limb body structure/function or activity limitation outcome measures were included. Subgroup analyses were performed according to phase poststroke, device characteristics (ie, arm support, joints involved, unimanual or bimanual training), NIBS paradigm, timing of stimulation, and number of sessions. The Grade-Pro Software was used to assess quality of the evidence. RESULTS: A nonsignificant homogeneous summary effect size was found both for body structure function domain (mean difference [MD] = 0.15; 95% CI = -3.10 to 3.40; P = 0.93; I2 = 0%) and activity limitation domain (standard MD = 0.03; 95% CI = -0.28 to 0.33; P = 0.87; I2 = 0%). CONCLUSIONS: According to this systematic review and meta-analysis, at the moment, there are not enough data about the benefits of NIBS as an add-on intervention to robot-assisted therapy on upper-limb motor function or activity in individuals with stroke.
引用
- Reis SB, Bernardo WM, Oshiro CA, et al. Effects of Robotic Therapy Associated With Noninvasive Brain Stimulation on Upper-Limb Rehabilitation After Stroke: Systematic Review and Meta-analysis of Randomized Clinical Trials. Neurorehabil Neural Repair. 2021. PMID: 33522417. doi:10.1177/1545968321989353
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。